{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:41:47Z","timestamp":1791283307775,"version":"4.1.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1097\/hjh.0b013e3282e9a72d","type":"journal-article","created":{"date-parts":[[2009,3,3]],"date-time":"2009-03-03T22:07:39Z","timestamp":1236118059000},"page":"2345-2351","source":"Crossref","is-referenced-by-count":37,"title":["Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure"],"prefix":"10.1097","volume":"25","author":[{"given":"Nimit C","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart D","family":"Pringle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan D","family":"Struthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-24-20210208","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-24-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-24-20210208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"R4-24-20210208","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"R5-24-20210208","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease","volume":"76","author":"Barr","year":"1995","journal-title":"Am J Cardiol"},{"key":"R6-24-20210208","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1161\/CIRCULATIONAHA.104.503706","article-title":"Conditional mineralocorticoid receptor expression in the heart leads to life-threatening arrhythmias","volume":"111","author":"Ouvrard-Pascaud","year":"2005","journal-title":"Circulation"},{"key":"R7-24-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0024-3205(62)90021-8","article-title":"Ectopic arrhythmia provoking action of aldosterone","volume":"1","author":"Arora","year":"1962","journal-title":"Life Sci"},{"key":"R8-24-20210208","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000142858.44680.27","article-title":"Cardiac specific increase in aldosterone production induces coronary dysfunction in aldosterone synthase-transgenic mice","volume":"110","author":"Garnier","year":"2004","journal-title":"Circulation"},{"key":"R9-24-20210208","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1161\/CIRCULATIONAHA.106.634626","article-title":"High plasma aldosterone levels on admission are associated with death in patients presenting with acute ST-elevation myocardial infarction","volume":"114","author":"Beygui","year":"2006","journal-title":"Circulation"},{"key":"R10-24-20210208","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/cs1030425","article-title":"Aldosterone induces acute endothelial dysfunction in vivo in humans: evidence for an aldosterone-induced vasculopathy","volume":"103","author":"Farquharson","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"R11-24-20210208","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"R12-24-20210208","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/01.CIR.0000022140.61460.1D","article-title":"Allopurinol improves endothelial dysfunction in chronic heart failure","volume":"106","author":"Farquharson","year":"2002","journal-title":"Circulation"},{"key":"R13-24-20210208","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/S0735-1097(01)01243-8","article-title":"Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure","volume":"37","author":"Yee","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R14-24-20210208","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/hrt.2003.017368","article-title":"Effects of spironolactone on endothelial function, vascular angiotensin converting enzyme activity, and other prognostic markers in patients with mild heart failure already taking optimal treatment","volume":"90","author":"Macdonald","year":"2004","journal-title":"Heart"},{"key":"R15-24-20210208","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/01.HYP.25.5.918","article-title":"Measuring forearm blood flow and interpreting the responses to drugs and mediators","volume":"25","author":"Benjamin","year":"1995","journal-title":"Hypertension"},{"key":"R16-24-20210208","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/01.CIR.93.6.1155","article-title":"C-type natriuretic peptide. An endogenous inhibitor of vascular angiotensin-converting enzyme activity","volume":"93","author":"Davidson","year":"1996","journal-title":"Circulation"},{"key":"R17-24-20210208","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/eurheartj\/12.11.1153","article-title":"Evaluation of the Reynolds Pathfinder II system for 24 h heart rate variability analysis","volume":"12","author":"Molgaard","year":"1991","journal-title":"Eur Heart J"},{"key":"R18-24-20210208","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.93.5.1043","article-title":"Heart rate variability: standards of measurement, physiological interpretation and clinical use.","volume":"93","year":"1996","journal-title":"Circulation"},{"key":"R19-24-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1046\/j.1365-2796.1999.00509.x","article-title":"Ventricular arrhythmias during 24-h ambulatory ECG recording: incidence, risk factors and prognosis in men with and without a history of cardiovascular disease","volume":"246","author":"Engstrom","year":"1999","journal-title":"J Intern Med"},{"key":"R20-24-20210208","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1136\/hrt.2005.070714","article-title":"Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina","volume":"92","author":"Lanza","year":"2006","journal-title":"Heart"},{"key":"R21-24-20210208","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0002-9149(96)90582-2","article-title":"Use of ventricular premature complexes for risk stratification after acute myocardial infarction in the thrombolytic era","volume":"77","author":"Statters","year":"1996","journal-title":"Am J Cardiol"},{"key":"R22-24-20210208","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/01.CIR.0000141729.01918.D4","article-title":"Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction","volume":"110","author":"Teo","year":"2004","journal-title":"Circulation"},{"key":"R23-24-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/euhj.1999.1739","article-title":"Diurnal, weekly and seasonal variation of sudden death. Population-based analysis of 24,061 consecutive cases","volume":"21","author":"Arntz","year":"2000","journal-title":"Eur Heart J"},{"key":"R24-24-20210208","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1046\/j.1460-9592.2003.00124.x","article-title":"Circadian variations in the occurrence of ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators","volume":"26","author":"Kozak","year":"2003","journal-title":"Pacing Clin Electrophysiol"},{"key":"R25-24-20210208","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the Randomized Aldactone Evaluation Study (RALES). Rales Investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"},{"key":"R26-24-20210208","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"R27-24-20210208","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00045415-200203000-00008","article-title":"Aldosterone as a mediator in cardiovascular injury","volume":"10","author":"Stier","year":"2002","journal-title":"Cardiol Rev"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004872-200711000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:58:39Z","timestamp":1618365519000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200711000-00024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e3282e9a72d","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}